Aldurazyme laronidase enzyme replacement therapy regulatory update

The FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted unanimously that the companies demonstrated meaningful treatment effects of their Aldurazyme therapeutic for mucopolysaccharidosis...